Policy | July 10, 2022
AbTis will have access to WuXi XDC's integrated services for linker and payload manufacturing
The acquisition continues the growth and expansion course of the ALPLApharma business division established in 2019
Krsnaa Diagnostics now has its footprints in Delhi.
CEPI will provide seed funding of up to US$2.5 million to Codiak BioSciences.
The AICVD tool can predict the risk of cardiovascular disease.
Vaccizone’s ASC Technology is an enhanced antigen/bioactive delivery method based on Antigen Presenting Cells
Medicines, including insulin, to be available in 40 lower-income countries
The Government of Quebec, through its agent Investissement Quebec, is granting a loan of CAD 25 million
105 million 30 µg, 10 µg and 3 µg doses to be delivered into Q4 2022, with an option for the U.S. Government to purchase up to 195 million additional doses
Subscribe To Our Newsletter & Stay Updated
